Pay in 4 interest-free payments of $42.82 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
and postnatal growth
Bevacizumab was the first clinically available angiogenesis inhibitor in the United States
KDM6A / UTX Antibody
GeneID: 26735
C12orf29 Polyclonal Antibody-BS76548 primary and hard-to-transfect cells and postnatal growthC12orf29 Polyclonal Antibody Sizes: 50l, 100l Catalogue Numbers: BS76548 50, BS76548 100 Product: 1mg ml in PBS with 0. 02% sodium azide, 50% glycerol, pH7. 2 Swiss Prot: Q8N999 Host: Rabbit Reactivity: Human, Mouse Applications: WB All Applications: WB,1: 500 1: 2000 Background: Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Purification and Purity: The antibody was affinity purified from rabbit antiserum by
US$ 20.70
US$ 21.62
US$ 29.95
US$ 39.48
US$ 18.95